Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retargeting gene delivery using surface-engineered retroviral vector particles.

D Lavillette1, S J Russell, F L Cosset

  • 1Laboratoire de Vectorologie Rétrovirale et Thérapie Génique, Unité de Virologie Humaine, INSERM U412, Ecole Normale Supérieure de Lyon, 46 allée d'Italie, 69364 Cedex 07, Lyon, France.

Current Opinion in Biotechnology
|October 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIWIs, piRNAs and Retrotransposons: Complex battles during reprogramming in gametes and early embryos.

Reproduction in domestic animals = Zuchthygiene·2017
Same author

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

Blood cancer journal·2017
Same author

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Leukemia·2017
Same author

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.

Leukemia·2017
Same author

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma.

Blood cancer journal·2017
Same author

Natural history of t(11;14) multiple myeloma.

Leukemia·2017
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
Same journal

Advancing in vitro gut fermentation: the convergence of gut-on-a-chip and digital twins.

Current opinion in biotechnology·2026
See all related articles

Researchers are developing new strategies for retroviral vectors to improve gene delivery. These advanced vectors aim to overcome previous limitations in targeting specific tissues for in vivo gene transfer applications.

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Retroviral vectors are crucial for in vivo gene transfer, enabling targeted delivery of transgenes to specific tissues.
  • Previous efforts to engineer vector host-range by surface ligand insertion often failed due to reduced vector fusogenicity upon binding target cells.
  • This impairment of fusogenic activity hinders effective gene delivery in targeted applications.

Purpose of the Study:

  • To explore novel strategies for enhancing the fusogenic activity of surface-engineered retroviral vectors.
  • To overcome the limitations of previous host-range modification attempts.
  • To enable more efficient and specific in vivo gene transfer.

Main Methods:

  • Investigated various strategies to restore fusogenic activity in modified retroviral vector particles.

Related Experiment Videos

  • Focused on surface engineering of vector glycoproteins.
  • Explored novel concepts in retroviral vector design.

    • Main Results:

    • Identified and explored several promising strategies to recover vector fusogenic activity.
    • These strategies have led to the development of novel concepts in the field of retroviral vector engineering.
    • Demonstrated potential for improved targeted gene delivery.

    Conclusions:

    • Novel strategies have been developed to overcome the fusogenicity issues in surface-engineered retroviral vectors.
    • These advancements pave the way for more effective in vivo gene transfer applications.
    • The field is progressing towards highly specific and efficient gene delivery systems.